Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases

Table 2

BDNF serum levels (mean ± SD) in patients taking (+) and not taking (−) different psychotropic drugs.

Pharmacological treatment	𝑁	BDNF ng/mL
Neuroleptics (+)	239	33.06 ± 10.65
Neuroleptics (−)	216	34.50 ± 12.15
Benzodiazepines (+)	155	32.02 ± 9.81
Benzodiazepines (−)	300	34.64 ± 12.06
Antidepressants (+)	237	33.14 ± 11.05
Antidepressants (−)	218	34.40 ± 11.76
Mood stabilizers antiepileptics (+)	57	37.43 ± 12.32
Mood stabilizers antiepileptics (−)	398	33.21 ± 11.18
Cholinesterase inhibitors (+)	97	32.36 ± 10.64
Cholinesterase inhibitors (−)	358	34.12 ± 11.58
L-DOPA (+)	30	46.13 ± 15.30
L-DOPA (−)	425	32.87 ± 10.56